Plasma B-type natriuretic peptide levels in systolic heart failure: importance of left ventricular diastolic function and right ventricular systolic function
- PMID: 15013124
- DOI: 10.1016/j.jacc.2003.08.046
Plasma B-type natriuretic peptide levels in systolic heart failure: importance of left ventricular diastolic function and right ventricular systolic function
Abstract
Objectives: This study was designed to characterize the importance of echocardiographic indexes, including newer indexes of diastolic function, as determinants of plasma B-type natriuretic peptide (BNP) levels in patients with systolic heart failure (SHF).
Background: Plasma BNP levels have utility for diagnosing and managing heart failure. However, there is significant heterogeneity in BNP levels that is not explained by left ventricular size and function alone.
Methods: In 106 patients with symptomatic SHF (left ventricular ejection fraction [LVEF] <0.35), we measured plasma BNP levels and performed comprehensive echocardiography with assessment of left ventricular diastolic function, including color M-mode (CMM) and tissue Doppler imaging (TDI), and of right ventricular (RV) function.
Results: Median plasma BNP levels were elevated and increased with greater severity of diastolic dysfunction. We found significant correlations (p < 0.001 for all) between BNP and indexes of myocardial relaxation (early diastolic velocity: r = -0.26), compliance (deceleration time: r = -0.55), and filling pressure (early transmitral to early annular diastolic velocity ratio: r = 0.51; early transmitral flow to the velocity of early left ventricular flow propagation ratio: r = 0.41). In multivariate analysis, overall diastolic stage, LVEF, RV systolic dysfunction, mitral regurgitation (MR) severity, age and creatinine clearance were independent predictors of BNP levels (model fit r = 0.8, p < 0.001).
Conclusions: Plasma BNP levels are significantly related to newer diastolic indexes measured from TDI and CMM in SHF. Heterogeneity of BNP levels in patients with SHF reflects the severity of diastolic abnormality, RV dysfunction, and MR in addition to LVEF, age, and renal function. These findings may explain the powerful relationship of BNP to symptoms and prognosis in SHF.
Similar articles
-
Prognostic value of tissue Doppler right ventricular systolic and diastolic function indexes combined with plasma B-type natriuretic Peptide in patients with advanced heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.Am J Cardiol. 2010 Jan 15;105(2):249-54. doi: 10.1016/j.amjcard.2009.08.682. Am J Cardiol. 2010. PMID: 20102927 Clinical Trial.
-
The relationship between B-type natriuretic peptide levels and echocardiographic parameters in patients with heart failure admitted to the emergency department.Anadolu Kardiyol Derg. 2010 Apr;10(2):143-9. doi: 10.5152/akd.2010.040. Anadolu Kardiyol Derg. 2010. PMID: 20382614
-
B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure.J Am Coll Cardiol. 2006 Feb 21;47(4):742-8. doi: 10.1016/j.jacc.2005.11.030. Epub 2006 Jan 26. J Am Coll Cardiol. 2006. PMID: 16487838
-
Utility of B-natriuretic peptide in the evaluation of left ventricular diastolic function and diastolic heart failure.Curr Opin Cardiol. 2009 Mar;24(2):155-60. doi: 10.1097/HCO.0b013e328320d82a. Curr Opin Cardiol. 2009. PMID: 19532102 Review.
-
Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.Dan Med Bull. 2001 Nov;48(4):199-210. Dan Med Bull. 2001. PMID: 11767125 Review.
Cited by
-
Elabela: A Novel Biomarker for Right Ventricular Pressure Overload in Children With Pulmonary Stenosis or Pulmonary Atresia With Intact Ventricular Septum.Front Cardiovasc Med. 2020 Nov 12;7:581848. doi: 10.3389/fcvm.2020.581848. eCollection 2020. Front Cardiovasc Med. 2020. PMID: 33282918 Free PMC article.
-
Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure.Vasc Health Risk Manag. 2010 Jun 1;6:411-8. doi: 10.2147/vhrm.s5789. Vasc Health Risk Manag. 2010. PMID: 20539843 Free PMC article. Review.
-
Treatment of sleep apnea in congestive heart failure with a dental device: the effect on brain natriuretic peptide and quality of life.Sleep Breath. 2006 Jun;10(2):90-7. doi: 10.1007/s11325-006-0053-2. Sleep Breath. 2006. PMID: 16534592
-
Atrial and Brain Natriuretic Peptides- Benefits and Limits of their use in Cardiovascular Diseases.Curr Cardiol Rev. 2019;15(4):283-290. doi: 10.2174/1573403X15666190326150550. Curr Cardiol Rev. 2019. PMID: 30914031 Free PMC article. Review.
-
Usefulness of plasma galectin-3 levels in systolic heart failure to predict renal insufficiency and survival.Am J Cardiol. 2011 Aug 1;108(3):385-90. doi: 10.1016/j.amjcard.2011.03.056. Epub 2011 May 19. Am J Cardiol. 2011. PMID: 21600537 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical